This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Bayer Intellectual Property Gmbh. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Stéphane Caillon-Morisseau: Innovator in Tetrazole Chemistry
Introduction: Stéphane Caillon-Morisseau is a notable inventor based in Lyons, France. He has made significant contributions to the field of chemistry, particularly in the development of a specific process that enhances the production of pharmacologically relevant compounds.
Latest Patents: Stéphane holds a patent for a process for the preparation of 5-substituted 1-alkyltetrazoles. This innovative method can potentially lead to advancements in pharmaceutical applications, showcasing his expertise in chemical processes.
Career Highlights: He is currently employed at Bayer Intellectual Property GmbH, where he continues to be at the forefront of innovation in his field. His work at Bayer emphasizes his commitment to pushing the boundaries of science and technology in drug development.
Collaborations: Throughout his career, Stéphane has collaborated with esteemed colleagues such as Pierre-Yves Coqueron and Jens-Dietmar Heinrich. These collaborations have allowed him to exchange ideas and enhance his research output, contributing to advancements in their shared fields of interest.
Conclusion: Stéphane Caillon-Morisseau stands out as an influential inventor in the realm of tetrazole chemistry. His patented processes and collaborative efforts reflect a dedicated pursuit of innovation that benefits the broader scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile